Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histological Response”

1,466 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,466 results

Testing effectiveness (Phase 2)Ended earlyNCT01625741
What this trial is testing

Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Testing effectiveness (Phase 2)Ended earlyNCT01666431
What this trial is testing

Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment

Who this might be right for
Squamous Cell Carcinoma
University of Zurich 10
Not applicableStudy completedNCT04920162
What this trial is testing

Search for New Predictive Markers of the Immune Response in Vitiligo and Melanoma

Who this might be right for
Melanoma and Vitiligo
Centre Hospitalier Universitaire de Nice 10
Early research (Phase 1)Study completedNCT01116804
What this trial is testing

Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)

Who this might be right for
Primary Liver Cancer
University Hospital, Ghent 36
Very early researchStudy completedNCT05704933
What this trial is testing

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Who this might be right for
Metastatic MelanomaMetastasis to Brain
H. Lee Moffitt Cancer Center and Research Institute 1
Not applicableStudy completedNCT00213876
What this trial is testing

Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours

Who this might be right for
Oligodendrogliomas
University Hospital, Strasbourg, France 189
Not applicableStudy completedNCT01715077
What this trial is testing

Study of Ipilimumab in the Immune System

Who this might be right for
Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
University Health Network, Toronto 4
Very early researchActive Not RecruitingNCT03044977
What this trial is testing

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting
David Bushnell 20
Not applicableUnknownNCT05641012
What this trial is testing

Association Between Helioderma and Response to Immunotherapy in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Institut Jean-Godinot 100
Early research (Phase 1)Study completedNCT00815607
What this trial is testing

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 12
Post-approval studies (Phase 4)Study completedNCT00171899
What this trial is testing

Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 80
Not applicableEnded earlyNCT04488263
What this trial is testing

Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s

Who this might be right for
Neuroendocrine TumorsCarcinoma, Neuroendocrine
National Cancer Institute (NCI) 30
Not applicableNot Yet RecruitingNCT07542912
What this trial is testing

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Who this might be right for
Complete Remission Rate， CRRProgression Free SurvivalOverall Survival+2 more
Sun Yat-sen University 30
Not applicableLooking for participantsNCT07303712
What this trial is testing

Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90

Who this might be right for
Hepatocellular Carcinoma (HCC)
Palo Alto Veterans Institute for Research 12
Not applicableLooking for participantsNCT05527795
What this trial is testing

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

Who this might be right for
Melanoma
Hospices Civils de Lyon 1,000
Early research (Phase 1)Study completedNCT00698100
What this trial is testing

Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines

Who this might be right for
MelanomaSkin
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT02451592
What this trial is testing

Fungemia in Hematologic Malignancies

Who this might be right for
Acute LeukemiaChronic LeukemiaMultiple Myeloma+1 more
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne 300
Early research (Phase 1)Ended earlyNCT01216436
What this trial is testing

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Duke University 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202
What this trial is testing

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more
City of Hope Medical Center 155
Not applicableActive Not RecruitingNCT04358107
What this trial is testing

Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

Who this might be right for
Adrenocortical Carcinoma
National Cancer Institute (NCI) 1,000
Next Page